Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry

Authors
Cheol Ung ChoiSeung-Woon RhaDong Joo OhKanhaiya L. PoddarJin Oh NaJin Won KimHong Euy LimEung Ju KimChang Gyu ParkHong Seog SeoTaek Jong HongJong-Seon ParkYoung Jo KimSeung Ho HurIn Whan SeongJei Keon ChaeMyeong Chan ChoJang Ho BaeDong Hoon ChoiYang Soo JangIn Ho ChaeHyo Soo KimChong Jin KimJung Han YoonTae Hoon AhnSeung-Jea TahkWook Sung ChungKi Bae SeungShung Chall ChaeSeung Jung ParkYoung Keun AhnMyung Ho Jeong
Department
Dept. of Internal Medicine (내과학); Cardiovascular Research Center (심혈관연구소)
Issue Date
2011
Citation
American Heart Journal, Vol.161(2) : 373-382, 2011
ISSN
0002-8703
Abstract
Background The optimal loading dose of clopidogrel in Asian patients with ST-segment elevation myocardial infarction (STEMI) has not been fully investigated. We compared bleeding, vascular complications, and midterm outcomes of a 300-mg versus a 600-mg loading dose of clopidogrel in a large series of Korean patients with STEMI undergoing primary percutaneous coronary intervention (PCI). Methods A total of 2,664 STEMI patients (age 61.96 ± 11.91 years, men 70.4%) who underwent primary PCI were enrolled in this study. The patients were divided into a standard loading dose group (300 mg; n = 1,447 patients) and a high loading dose group (600 mg; n = 1,217 patients). Bleeding and vascular complications, and in-hospital and clinical outcomes up to 12 months were compared between the 2 groups. Results In-hospital bleeding and vascular complications were similar between the 2 groups. There were no differences in bleeding and vascular complications and in 1- and 12-month clinical outcomes, including mortality, myocardial infarction, repeated PCI, and major adverse cardiac events, between the 2 groups. These findings were consistent even after the propensity score–matched analysis. Conclusions The standard loading dose of clopidogrel may be as safe and similarly effective as the high loading dose in Asian STEMI patients undergoing primary PCI. (Am Heart J 2011;161:373-382.e3.)
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/35431
Appears in Collections:
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
1. Journal Papers (연구논문) > 3. Research Institutues (연구소) > Cardiovascular Research Center (심혈관연구소)
Keimyung Author(s)
허승호
Full Text
https://linkinghub.elsevier.com/retrieve/pii/S0002870310009312
File in this Item
 사서에게 요청하기
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE